In this podcast, Daniel Fierer, MD, from the Icahn School of Medicine at Mt. Sinai, discusses treating and managing HIV-HCV coinfection in men who have sex with men.
In this podcast, Michael Reid, MD, from the University of California, San Francisco, discusses the prevalence of obesity in patients with HIV, HIV treatments that may lead to obesity, and other antiretroviral medications.
In this podcast, Rajesh Gandhi, MD, talks about what you should know about COVID-19 vaccines for your patients with HIV, including whether COVID-19 vaccines are safe for people with HIV, how managing patients with HIV has changed during the COVID-19 pandemic, and what research still needs to be done on COVID-19 vaccines and patients with HIV. He also presented on this topic at the annual ACT HIV 2021 meeting.
In this podcast, Jonathan Colasanti, MD, talks about caring for patients with HIV in 2021, including why some current care models are succeeding, why some are failing, and how to improve health outcomes for patients with HIV.
Joseph Logan, PhD, on Structural and Social Determinants of Health Associated With HIV Care for Black and White Adults
In this podcast, Joseph "J" Logan, PhD, discusses 3 structural social determinants of health associated with HIV care outcomes for Black people with HIV.
In this podcast, Vinay Pathak, PhD, discusses the implications of his research presented in the session “Live-Cell Imaging of HIV-1 Nuclear Import, Uncoating, and Proviruses” at the Conference on Retroviruses and Opportunistic Infections 2021.
In this podcast, Jonathan Karn, PhD, talks about his session "Novel Findings of Neuronal Modulation of HIV Expression in Microglia" at the Conference on Retroviruses and Opportunistic Infections 2021, including some controversies among researchers about HIV infection of the brain.
In this podcast, Raeanne Moore, PhD, and Maulika Kohli talk about their recent article, which investigated using technology to capture digital phenotyping data in HIV-associated neurocognitive disorders.
In this podcast, Dr Pinkston-Camp talks about whether a “brief advice about drinking” intervention or a “motivational interview" intervention could help reduce alcohol use among patients with HIV and hepatitis C virus—a high-risk group for liver disease progression and liver cancer.
In this podcast, Dr Webel talks about the aging population with HIV, what the 6M framework is and how health care providers can implement it in practice, and the pharmacologic and nonpharmacologic therapies on the horizon.